A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
NCT06660290
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
0.003% AR-15512 ophthalmic solution
DRUG:
Artificial tears
Sponsor
Alcon Research